Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation. [PDF]
Br J Clin Pharmacol, 2016 Sharma S +6 more
europepmc +1 more source
Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. [PDF]
Am J Obstet Gynecol, 2016 Manuck TA +4 more
europepmc +1 more source
Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate. [PDF]
J Matern Fetal Neonatal Med, 2012 Szychowski JM +9 more
europepmc +1 more source
The influence of prior obstetrical history on current 17-hydroxyprogesterone caproate use. [PDF]
J Pregnancy, 2011 Ransom CE +5 more
europepmc +1 more source
Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate. [PDF]
Am J Obstet Gynecol, 2013 Caritis SN +3 more
europepmc +1 more source
Progesterone Metabolites Produced by Cytochrome P450 3A Modulate Uterine Contractility in a Murine Model. [PDF]
Reprod Sci, 2015 Patil AS +5 more
europepmc +1 more source
What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. [PDF]
Semin Perinatol, 2016 Caritis SN +4 more
europepmc +1 more source
Quality assessment of compounded 17-hydroxyprogesterone caproate. [PDF]
Am J Obstet Gynecol, 2014 Chang J +5 more
europepmc +1 more source